Foros de Conocimiento
medtronic PRODUCTOS
boston_scientific PRODUCTOS
TERUMO PRODUCTOS
Biotronik PRODUCTOS
Sirtex PRODUCTOS
Striker Neurovascular PRODUCTOS
BIOSENSORS PRODUCTOS

ABSTRACT


01 noviembre 2016

JACC. Long-Term Prognostic Value of Cardiac Magnetic Resonance in Left Ventricle Noncompaction. A Prospective Multicenter Study

Daniele Andreini, Gianluca Pontone, Jan Bogaert, Alberto Roghi, Andrea Barison, Juerg Schwitter, Saima Mushtaq, Georgios Vovas, Paola Sormani, Giovanni D. Aquaro, Pierre Monney, Chiara Segurini, Marco Guglielmo, Edoardo Conte, Laura Fusini, Antonio Dello Russo, Massimo Lombardi, Paola Gripari, Andrea Baggiano, Cesare Fiorentini, Federico Lombardi, Antonio L. Bartorelli, Mauro Pepi, Pier Giorgio Masci

Background: Cardiac magnetic resonance (CMR) is useful for the diagnosis of left ventricular noncompaction (LVNC). However, there are limited data regarding its prognostic value.

01 noviembre 2016

JACC. Long-Term Outcomes in Patients With Aortic Regurgitation and Preserved Left Ventricular Ejection Fraction

Ejection Fraction Amgad Mentias, Ke Feng, Alaa Alashi, L. Leonardo Rodriguez, A. Marc Gillinov, Douglas R. Johnston, Joseph F. Sabik, Lars G. Svensson, Richard A. Grimm, Brian P. Griffin, Milind Y. Desai

Background: Chronic severe aortic regurgitation (AR) imposes significant volume and pressure overload on the left ventricle (LV), but such patients typically remain in an asymptomatic state for a very long time.

01 noviembre 2016

JACC. Serial Changes in Cognitive Function Following Transcatheter Aortic Valve Replacement

Vincent Auffret, Francisco Campelo-Parada, Ander Regueiro, María Del Trigo, Olivier Chiche, Chekrallah Chamandi, Ricardo Allende, Juan G. Cordoba-Soriano, Jean-Michel Paradis, Robert De Larochellière, Daniel Doyle, Eric Dumont, Siamak Mohammadi, Mélanie Côté, Alier Marrero, Rishi Puri, Josep Rodés-Cabau

Background: Data regarding the mid- to long-term cognitive trajectory of transcatheter aortic valve (TAVR) recipients are scarce.

01 noviembre 2016

JACC. High-Density Lipoprotein Cholesterol and Cause-Specific Mortality in Individuals Without Previous Cardiovascular Conditions. The CANHEART Study

Dennis T. Ko, David A. Alter, Helen Guo, Maria Koh, Geoffrey Lau, Peter C. Austin, Gillian L. Booth, William Hogg, Cynthia A. Jackevicius, Douglas S. Lee, Harindra C. Wijeysundera, John T. Wilkins, Jack V. Tu

Background: The prognostic importance of high-density lipoprotein cholesterol (HDL-C) as a specific risk factor for cardiovascular (CV) disease has been challenged by recent clinical trials and genetic studies.

01 noviembre 2016

JACC. Transcatheter Aortic Valve Thrombosis. Incidence, Predisposing Factors, and Clinical Implications

Nicolaj C. Hansson, Erik L. Grove, Henning R. Andersen, Jonathon Leipsic, Ole N. Mathiassen, Jesper M. Jensen, Kaare T. Jensen, Philipp Blanke, Tina Leetmaa, Mariann Tang, Lars R. Krusell, Kaj E. Klaaborg, Evald H. Christiansen, Kim Terp, Christian J. Terkelsen, Steen H. Poulsen, John Webb, Hans Erik Bøtker, Bjarne L. Nørgaard

Background: There are limited data on the incidence, clinical implications, and predisposing factors of transcatheter heart valve (THV) thrombosis following transcatheter aortic valve replacement (TAVR).

01 noviembre 2016

JACC. Long-Term Clinical Outcomes of Subcutaneous Versus Transvenous Implantable Defibrillator Therapy

Tom F. Brouwer, Dilek Yilmaz, Robert Lindeboom, Maurits S. Buiten, Louise R.A. Olde Nordkamp, Martin J. Schalij, Arthur A. Wilde, Lieselot van Erven, Reinoud E. Knops

Background: Transvenous implantable cardioverter-defibrillators (TV-ICDs) improve survival in patients at risk for sudden cardiac death, but complications remain an important drawback. The subcutaneous ICD (S-ICD) was developed to overcome lead-related complications. Comparison of clinical outcomes of both device types in previous studies was hampered by dissimilar patient characteristics.

01 noviembre 2016

JACC. The Cardiovascular Risk of White-Coat Hypertension

Stanley S. Franklin, Lutgarde Thijs, Kei Asayama, Yan Li, Tine W. Hansen, José Boggia, Lotte Jacobs, Zhenyu Zhang, Masahiro Kikuya, Kristina Björklund-Bodegård, Takayoshi Ohkubo, Wen-Yi Yang, Jørgen Jeppesen, Eamon Dolan, Tatiana Kuznetsova, Katarzyna Stolarz-Skrzypek, Valérie Tikhonoff, Sofia Malyutina, Edoardo Casiglia, Yuri Nikitin, Lars Lind, Edgardo Sandoya, Kalina Kawecka-Jaszcz, Jan Filipovský, Yutaka Imai, Ji-Guang Wang, Eoin O’Brien, Jan A. Staessen, IDACO Investigators

Background: The role of white-coat hypertension (WCH) and the white-coat-effect (WCE) in development of cardiovascular disease (CVD) risk remains poorly understood.

01 noviembre 2016

JACC. Strain Echocardiography and Functional Capacity in Asymptomatic Primary Mitral Regurgitation With Preserved Ejection Fraction

Amgad Mentias, Peyman Naji, A. Marc Gillinov, L. Leonardo Rodriguez, Grant Reed, Tomislav Mihaljevic, Rakesh M. Suri, Joseph F. Sabik, Lars G. Svensson, Richard A. Grimm, Brian P. Griffin, Milind Y. Desai

Background: The potential additive utility of baseline resting left ventricular global longitudinal strain (LV-GLS) and exercise stress testing in risk stratification of patients with significant mitral regurgitation (MR) has not been studied.

01 noviembre 2016

JACC. The Hybrid Algorithm for Treating Chronic Total Occlusions in Europe. The RECHARGE Registry

Joren Maeremans, Simon Walsh, Paul Knaapen, James C. Spratt, Alexandre Avran, Colm G. Hanratty, Benjamin Faurie, Pierfrancesco Agostoni, Erwan Bressollette, Peter Kayaert, Alan J. Bagnall, Mohaned Egred, Dave Smith, Alexander Chase, Margaret B. McEntegart, William H.T. Smith, Alun Harcombe, Paul Kelly, John Irving, Elliot J. Smith, Julian W. Strange, Joseph Dens

Background: The hybrid algorithm for chronic total occlusion (CTO) percutaneous coronary intervention (PCI) was developed to improve procedural outcomes. Large, prospective studies validating the algorithm in a broad multicenter setting with operators of different experience levels are lacking.

01 noviembre 2016

JACC. Left Atrial Appendage Isolation in Patients With Longstanding Persistent AF Undergoing Catheter Ablation. BELIEF Trial

Luigi Di Biase, J. David Burkhardt, Prasant Mohanty, Sanghamitra Mohanty, Javier E. Sanchez, Chintan Trivedi, Mahmut Güneş, Yalçın Gökoğlan, Carola Gianni, Rodney P. Horton, Sakis Themistoclakis, G. Joseph Gallinghouse, Shane Bailey, Jason D. Zagrodzky, Richard H. Hongo, Salwa Beheiry, Pasquale Santangeli, Michela Casella, Antonio Dello Russo, Amin Al-Ahmad, Patrick Hranitzky, Dhanunjaya Lakkireddy, Claudio Tondo, Andrea Natale

Background: Longstanding persistent (LSP) atrial fibrillation (AF) is the most challenging type of AF. In addition to pulmonary vein isolation, substrate modification and triggers ablation have been reported to improve freedom from AF in patients with LSPAF.

01 octubre 2016

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Complete Versus Culprit-Only Revascularization for Patients With Multi-Vessel Disease Undergoing Primary Percutaneous Coronary Intervention: An Updated Meta-Analysis of Randomized Trials

Islam Y. Elgendy MD, Xuerong Wen PhD, Ahmed Mahmoud MD, Anthony A. Bavry MD, MPH

Objectives: To perform an updated meta-analysis to determine whether complete revascularization of significant coronary lesions at the time of primary percutaneous coronary intervention (PCI) would be associated with better outcomes compared with culprit-only revascularization.

01 octubre 2016

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Ischemic Postconditioning After Routine Thrombus Aspiration During Primary Percutaneous Coronary Intervention: Rationale and Design of the POstconditioning Rotterdam Trial

Tuncay Yetgin MD, Matthijs van Kranenburg MD, Tim ten Cate MD, PhD, Dirk J. Duncker MD, PhD, Menko-Jan de Boer MD, PhD, Roberto Diletti MD, Robert-Jan M. van Geuns MD, PhD, Felix Zijlstra MD, PhD, Olivier C. Manintveld MD, PhD

Background: Whether ischemic postconditioning (IPOC) immediately after routine thrombus aspiration (TA) reduces infarct size (IS) in patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PPCI) has not been established.

01 octubre 2016

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. The influence of advancing age on implantation of drug-eluting stents

Wenjie Tian MD, Michael Mahmoudi MD, PhD, Thibault Lhermusier MD, Sarkis Kiramijyan MD, Fang Chen PhD, Rebecca Torguson MPH, William O. Suddath MD, Lowell F. Satler MD, Augusto D. Pichard MD, Ron Waksman MD

Background: The influence of age upon the use of drug-eluting stents (DES) in patients aged ≥ 65 years is uncertain. The aim of this study is to investigate the impact of age increase in patients aged ≥ 65 years in the use of DES in patients undergoing percutaneous coronary intervention (PCI).

01 octubre 2016

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Treatment of drug-eluting stent restenosis: Comparison between drug-eluting balloon versus second-generation drug-eluting stents from a retrospective observational study

Sandeep Basavarajaiah MD, MRCP, Toru Naganuma MD, Azeem Latib MD, Alessandro Sticchi MD, Giuseppe Ciconte MD, Vasilis Panoulas MD, Alaide Chieffo MD, Matteo Montorfano MD, Mauro Carlino MD, Antonio Colombo MD

Objectives: To compare drug-eluting balloons (DEBs) versus second-generation DES in the treatment of drug-eluting stent restenosis (DES-ISR).

Utilizamos cookies propias para el correcto funcionamiento del sitio web y mejorar nuestros servicios. Pulse el botón Aceptar todas para aceptar su uso. Puede cambiar la configuración u obtener más información en nuestra Política de cookies o pulsando Modificar configuración.